Abstract
We describe the development of a novel, high-throughput, nano-scale microarray platform for antimicrobial susceptibility testing (AST). The platform allows to process 480 samples at 50 nL volume on a single chip, analyze by fluorescence read-out with an easy dunk-and-rinse step, and the ability to process multiple samples and chips simultaneously. We demonstrate the applicability of this chip for culturing community acquired methicillin resistant Staphylococcus aureus (CA-MRSA), and perform AST against clinical isolates of CA-MRSA. The chip platform holds promise for an impact in microbial biotechnology as an attractive high-throughput, lower sample volume and quicker alternative to conventional AST such as the traditional broth microdilution or the newer automated systems.
Original language | English (US) |
---|---|
Pages (from-to) | 44-47 |
Number of pages | 4 |
Journal | Biotechnology Reports |
Volume | 16 |
DOIs | |
State | Published - Dec 2017 |
Keywords
- Antimicrobial susceptibility testing
- High-throughput
- Microarray
ASJC Scopus subject areas
- Biotechnology
- Applied Microbiology and Biotechnology